Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-27T13:01:09.563Z Has data issue: false hasContentIssue false

P-1067 - Neurosyphilis Presenting as Psychosis

Published online by Cambridge University Press:  15 April 2020

R. Abubaker
Affiliation:
Psychiatry, Atlanta VA Medical Center, East Point, Atlanta, GA, USA
D. Mendoza
Affiliation:
Psychiatry, Atlanta VA Medical Center, East Point, Atlanta, GA, USA Morehouse School of Medicine, Georgia Regional Hospital, Atlanta, GA, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

As we all know there has been a recent resurgence in the incidence of syphilis worldwide. Presented here is a case report of a 46 year old African- American male with no past psychiatric history, who presented with an acute onset of psychotic symptoms including delusions, hallucinations and aggressiveness. The patient was later diagnosed as having Neurosyphilis at a large community hospital and was started on benzathine penicillin G, 2.4 million units I/M every week for 3 weeks, and was later transferred to a state mental hospital to treat his psychosis. Patient was then tried on quetiapine with the target bid dose of 400 mg (am) and 600 mg (pm) along with benztropine 2 mg tid. After 3 weeks, the patient's hallucinations and aggressiveness improved, his EPS also became better. One of the objectives of this case report is to compare the patient's response to different trials of antipsychotics and to also emphasize the importance of routine screening for syphilis as part of the diagnostic work up of psychosis.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.